Analystreport

Castle Biosciences, Inc. (NASDAQ: CSTL) had its price target lowered by analysts at Robert W. Baird from $48.00 to $41.00.

Castle Biosciences, Inc. - Common stock  (CSTL) 
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm Check Earnings Report